# Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture

> **NCT02738073** · NA · UNKNOWN · sponsor: **Rothman Institute Orthopaedics**

## Conditions studied

- Hip Fracture

## Interventions

- **DRUG:** Control: Saline
- **DRUG:** Tranexamic Acid

## Key facts

- **NCT ID:** NCT02738073
- **Lead sponsor:** Rothman Institute Orthopaedics
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** —
- **Primary completion:** 2017-02
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02738073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02738073, "Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02738073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*